Intuitive Surgical Inc. (NASDAQ:ISRG) will be releasing its earnings data on Tuesday, October 18th. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 19th. The company reported $5.62 EPS for the quarter, topping the Zacks’ consensus estimate of $4.97 by $0.65. The business had revenue of $670 million for the quarter, compared to the consensus estimate of $640.69 million. Intuitive Surgical had a net margin of 26.80% and a return on equity of 15.25%. During the same period in the prior year, the firm earned $4.57 EPS. On average, analysts expect Intuitive Surgical to post $21.30 EPS for the current fiscal year and $24.20 EPS for the next fiscal year.

Earnings History for Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical Inc. (NASDAQ:ISRG) opened at 713.44 on Friday. The firm has a 50-day moving average of $700.61 and a 200-day moving average of $662.91. The company has a market capitalization of $27.46 billion, a P/E ratio of 40.49 and a beta of 0.72. Intuitive Surgical Inc. has a 52 week low of $461.05 and a 52 week high of $727.25.

In related news, CEO Gary S. Guthart sold 13,400 shares of the business’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $698.00, for a total value of $9,353,200.00. Following the completion of the sale, the chief executive officer now directly owns 78,780 shares in the company, valued at approximately $54,988,440. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Mark J. Meltzer sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, August 22nd. The stock was sold at an average price of $688.33, for a total value of $2,064,990.00. Following the completion of the sale, the senior vice president now owns 2,331 shares of the company’s stock, valued at $1,604,497.23. The disclosure for this sale can be found here. 3.10% of the stock is owned by corporate insiders.

A number of large investors have recently bought and sold shares of ISRG. WESPAC Advisors SoCal LLC raised its stake in Intuitive Surgical by 33.9% in the second quarter. WESPAC Advisors SoCal LLC now owns 395 shares of the company’s stock valued at $261,000 after buying an additional 100 shares during the period. Salem Investment Counselors Inc. bought a new stake in Intuitive Surgical during the second quarter valued at $324,000. WFG Advisors LP raised its stake in Intuitive Surgical by 3.9% in the second quarter. WFG Advisors LP now owns 533 shares of the company’s stock valued at $353,000 after buying an additional 20 shares during the period. Advisor Group Inc. bought a new stake in Intuitive Surgical during the second quarter valued at $394,000. Finally, Bank of Nova Scotia raised its stake in Intuitive Surgical by 8.6% in the second quarter. Bank of Nova Scotia now owns 755 shares of the company’s stock valued at $499,000 after buying an additional 60 shares during the period. Hedge funds and other institutional investors own 91.90% of the company’s stock.

A number of equities analysts have commented on the stock. Barclays PLC reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on Saturday, June 18th. Wells Fargo & Co. assumed coverage on shares of Intuitive Surgical in a research note on Thursday. They set an “outperform” rating on the stock. Piper Jaffray Cos. reaffirmed a “neutral” rating and set a $700.00 target price (up from $610.00) on shares of Intuitive Surgical in a research note on Wednesday, July 20th. Zacks Investment Research downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Monday, June 27th. Finally, Canaccord Genuity lifted their target price on shares of Intuitive Surgical from $700.00 to $750.00 and gave the stock a “buy” rating in a research note on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $701.42.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.